Marathon Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GSK
GSK
|
+$2.17M |
| 2 |
CRCM
CARE.COM, INC.
CRCM
|
+$2.15M |
| 3 |
PARA
Paramount Global Class B
PARA
|
+$1.93M |
| 4 |
GIMO
Gigamon Inc.
GIMO
|
+$1.49M |
| 5 |
Howmet Aerospace
HWM
|
+$1.43M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SAAS
inContact, Inc.
SAAS
|
+$3.14M |
| 2 |
Kopin
KOPN
|
+$2.38M |
| 3 |
Alcoa
AA
|
+$2.14M |
| 4 |
TNGO
Tangoe, Inc.
TNGO
|
+$1.39M |
| 5 |
Prudential Financial
PRU
|
+$1.33M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 52.14% |
| 2 | Technology | 17.71% |
| 3 | Industrials | 7.98% |
| 4 | Materials | 5.66% |
| 5 | Healthcare | 4.14% |
Similar funds
Marathon Capital Management's Q4 2016 Portfolio in Review
As of Q4 2016, Marathon Capital Management held 101 positions worth $210M, up 4.3% from $201M the previous quarter. Its ten largest holdings account for 73% of the portfolio.
Marathon Capital Management withdrew a net $7.1M in Q4 2016, closing 15 positions and reducing 42 holdings. Its most notable exit was inContact, Inc., an estimated $3.14M position sold in full.
By sector, the portfolio is most concentrated in Financials at 52% of assets, up from 50% a quarter earlier, followed by Technology and Industrials.
Against the trend, Marathon Capital Management opened a new position in CARE.COM, INC. worth $2.09M.
- Marathon Capital Management's largest Q4 2016 buy was CARE.COM, INC.: 244,000 shares worth $2.09M.
- Marathon Capital Management added most to GSK in Q4 2016, an estimated $2.17M increase.
- Marathon Capital Management's biggest Q4 2016 reduction was Kopin, cutting an estimated $2.38M.
- Marathon Capital Management fully exited inContact, Inc. in Q4 2016, selling an estimated $3.14M.
- Marathon Capital Management's ten largest holdings make up 73% of its $210M portfolio in Q4 2016.
- Marathon Capital Management opened 9 new positions and closed 15 in Q4 2016.
- Marathon Capital Management's portfolio value rose 4.3% quarter-over-quarter to $210M.
Based on Marathon Capital Management's 13F filing for Q4 2016, filed 7 Feb 2017.